← Back to headlines
ResMed Downgraded by RBC Capital Markets Amid FY27 Challenges
ResMed has been downgraded by RBC Capital Markets, citing challenges anticipated for the company in fiscal year 2027.
16 Jul, 17:00 — 16 Jul, 17:00
Sources
Showing 1 of 1 sources
Related Stories
Airbus Seeks Sale of U.S. Space Unit to Bolster European Satellite Alliance
16m ago
Fed Chair Warsh Signals Potential Rate Hikes Amid Stubborn Inflation
1h ago
Temasek Backs Singapore Airlines’ Investment in Air India Amid Scrutiny
1h ago
Dolly Parton’s Business Strategy and Cultural Legacy Examined
1h ago